Concepedia

Holly Galavotti

HG

Statistics

Publications

6

Citations

968

H-Index

6

Active since

1999

Affiliations

University of Virginia(Current)

Carter Center

Holly Galavotti is an author at University of Virginia specializing in immunology, autoimmunity, and tumor immunity.

Top concepts

Publications per year

1999–2005

6

Publications

6

Clinical and Immunologic Results of a Randomized Phase II Trial of Vaccination Using Four Melanoma Peptides Either Administered in Granulocyte-Macrophage Colony-Stimulating Factor in Adjuvant or Pulsed on Dendritic Cells

Craig L. Slingluff, Gina R. Petroni, Galina V. Yamshchikov et al. · Journal of Clinical Oncology · 2003 · 321 citations

Phase I trial of a melanoma vaccine with gp100(280-288) peptide and tetanus helper peptide in adjuvant: immunologic and clinical outcomes.

Craig L. Slingluff, Galina V. Yamshchikov, Patrice Y. Neese et al. · PubMed · 2001 · 229 citations

, , +18

Terminal modifications inhibit proteolytic degradation of an immunogenic mart-127-35 peptide: Implications for peptide vaccines

Laurence H. Brinckerhoff, Lee W. Thompson, Galina V. Yamshchikov et al. · International Journal of Cancer · 1999 · 168 citations

, , +22

Evaluation of peptide vaccine immunogenicity in draining lymph nodes and peripheral blood of melanoma patients

Galina V. Yamshchikov, Donna L. Barnd, Shannon Eastham et al. · International Journal of Cancer · 2001 · 115 citations

Sequential Immune Escape and Shifting of T Cell Responses in a Long-Term Survivor of Melanoma

Galina V. Yamshchikov, David W. Mullins, Chien‐Chung Chang et al. · The Journal of Immunology · 2005 · 93 citations · Full text

1–5 of 6